...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
DHR NYSE 🇺🇸 US
Danaher Corp.
Healthcare
Not a Dip
Price Zone: Consider Trimming
🔒 Full AI Analysis — Pro
16Score
DipBuster Score™
$229.75 $4.11 (-1.76%) Live price · Source: Yahoo
52-Week Position
$160.93 84% of range $242.80
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$242.80
52W Low$160.93
DipBuster Brief Key signals at a glance
Zone: Consider Trimming
Bearish
Near 52-Week High — Asymmetric Risk
At 84% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position84% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at Danaher Corp. (DHR), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-10-09 Rales Mitchell P SELL 500,000
2026-10-09 Rales Steven M SELL 500,000
2026-08-21 Blair Rainer SELL 7,755
2026-08-21 Blair Rainer SELL 39,193
2026-08-21 Blair Rainer SELL 11,307
2026-08-04 Gugino Matthew E BUY 153,563
2026-08-04 Milosevich Gregory M BUY 15,402
2026-08-04 Sawyer Montgomery Julie A BUY 245,701
2026-08-04 Riley Christopher Paul BUY 41,072
2026-08-04 Bouda Christopher BUY 12,286

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$242.80
52W Low$160.93

52-Week Range

$160.93Now$242.80
84% through annual range
From 52W High−5.4%
From 52W Low+42.8%
📖 Plain English Summary
Danaher Corp. is at 84% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for DHR 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — DHR
Heuristic · balance sheet, insider filings, price data, academic research

Danaher Corp. — DipBuster Score 16/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track Danaher Corp. free

Add DHR to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 6/25
Momentum & Volume 5/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
4 /100 · NEUTRAL
dip depth 4/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 16/100
📊 Run a full check in the AI analysis tab for a deeper look.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificMDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificEW Edwards LifesciencesAll Healthcare stocks →